Patient-Reported Discontinuation of Endocrine Therapy and Related Adverse Effects Among Women With Early-Stage Breast Cancer-Reference-Cited by-同舟云学术

Patient-Reported Discontinuation of Endocrine Therapy and Related Adverse Effects Among Women With Early-Stage Breast Cancer

Published:2012-11 Issue:6 Volume:8 Page:e149-e157
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Aiello Bowles Erin J.¹,Boudreau Denise M.¹,Chubak Jessica¹,Yu Onchee¹,Fujii Monica¹,Chestnut Janet¹,Buist Diana S.M.¹

Affiliation:

1. Group Health Research Institute; and Group Health Physicians, Seattle, WA

Abstract

Few individual adverse effects or patient characteristics were significantly associated with endocrine therapy discontinuation, yet adverse effects were prevalent and were the most commonly reported reason for discontinuation.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology(nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2012.000543

Reference35 articles.

1. Adjuvant Endocrine Therapy in Hormone Receptor-Positive Postmenopausal Breast Cancer: Evolution of NCCN, ASCO, and St Gallen Recommendations

2. Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review

3. Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer

4. Predictors of Tamoxifen Discontinuation Among Older Women With Estrogen Receptor–Positive Breast Cancer

5. Early discontinuation of tamoxifen

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Motivational Interviewing on Psychosocial and Symptom Outcomes During Breast Cancer Endocrine Therapy;2024-09-03

2. A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer;Current Oncology;2024-08-07

3. Insights Into the Patient Experience of Hormone Therapy for Early Breast Cancer Treatment Using Patient Forum Discussions and Natural Language Processing;JCO Clinical Cancer Informatics;2024-08

4. A randomized trial of the impact of symptom monitoring using an electronic patient-reported outcome app on health-related quality of life in postmenopausal breast cancer patients receiving adjuvant endocrine therapy;Breast Cancer;2024-05-26

5. The REthinking Clinical Trials Program Retreat 2023: Creating Partnerships to Optimize Quality Cancer Care;Current Oncology;2024-03-06